期刊文献+

萘普生前药及其经皮渗透特征 被引量:2

Study on prodrugs of naproxen and their dermal permeability
下载PDF
导出
摘要 目的 研究萘普生前药的经皮渗透性。方法 合成萘普生酯作为萘普生的前药 ,考察这些前药的经皮渗透速率和在经皮渗透过程中被皮肤代谢的情况。结果 合成了 7个萘普生酯 ,其中萘普生薄荷酯的经皮渗透速率超过了萘普生的渗透速率 ,萘普生前药在经皮渗透过程中均能一定程度地被皮肤代谢。结论 萘普生酯的酯基为 8~ 10个碳链 ,有利于前药经皮渗透 。 OBJECTIVE To investigate the dermal permeability of naproxen's prodrugs.METHOD Synthesizing esters of naproxen as its prodrugs and testing their dermal permeability.RESULTS Seven esters of naproxen were synthesized, the dermal penetration rate of menthyl naproxen exceeded the rate of its matrix, naproxen's prodrugs were metabolized in a certain extent during penetration through skin.CONCLUSION The prodrug of naproxen with 8~10 carbon-chain ester group is propitious to dermal penetration and the lipophilic prodrug tends to be metabolized in skin.
作者 成志毅 朱辉
机构地区 中山大学药学院
出处 《中国现代应用药学》 CAS CSCD 北大核心 2004年第5期379-382,共4页 Chinese Journal of Modern Applied Pharmacy
关键词 萘普生 前药 合成 经皮渗透 naproxen prodrugs synthesis dermal penetration
  • 相关文献

参考文献5

  • 1朱辉,成志毅.经皮给药系统中前药应用的研究进展[J].国外医药(合成药.生化药.制剂分册),2002,23(2):106-108. 被引量:5
  • 2Bando H, Takagi T, Yamashita F, Theoretical design of prodrugenhancer combination based on a skin diffusion model: prediction of permeation of acyclovir prodrugs treated with 1 -geranylazacycloheptan-2-one[J]. Pharm Res, 1996, 13(3) :427.
  • 3Rautio J, Taipale H, Gynther J, et al. In Vitro Evaluation of acyloxyalkyl esters as dermal prodrugs of ketoprofen and naproxen [J]. J Pharm Sci, 1998, 87(12) :1622.
  • 4Rautio J, Nevalainen T, Taipale H et al. Synthesis and in vitro evaluation of novel morpholinyl- and methylpiperazinylacyloxyalkyl prodrugs of 2 - ( 6-methoxy-2-naphthyl ) propionic acid (Naproxen)for topical drug delivery[ J ]. J Med Chem, 2000 ;43:1489.
  • 5胡巧红,高建青,梁文权,包家立,平其能.电穿孔技术促进萘普生经皮渗透的研究[J].中国现代应用药学,2000,17(5):377-379. 被引量:7

二级参考文献10

  • 1Weaver JC. Electroporation: ageneral phenomenon for manipulating cell and tissues .J Cell Biochem, 1993,51:426.
  • 2Wang S, Kara M, Krishnan TR. Topical delivery of cyclosporin A coevaporate usingelectroporation technique. Drug Dev Ind Phar, 1997,23: 657.
  • 3Wang S, Kara M, Krishnan TR. Transdermal delivery of cyclosporin-A usingelectroporation. J Controlled Release, 1998,50:61.
  • 4Prausnitz MR, Edelman ER, Gimm JA, et al. Transdermal delivery of heparin by skinelectroporation. Bio/Technology, 1995,13: 1205.
  • 5Vanbever R, Lecouturier N, Preat V. Transdermal delivery of metoprolol byelectroporation. Pharm Res, 1994,11:1657.
  • 6Vanbever R, Boulenge EL, Preat V. Transdermal delivery of fentanyl byelectroporation Ⅰ . influence of electrical factors. Pharm Res, 1996,13:559.
  • 7Vanbever R, More ND, Preat V. Transdermal delivery of fentanyi by electroporation H. mechanisms involved in drug transport. Pharm Res, 1996,13:1360.
  • 8Vanbever R, Langers G, Montmayeur S, et al. Transdermal delivery of fentanyl: rapidonset of analgesia using skin eletroporation. J Controlled Release, 1998,50: 225.
  • 9Zewert TE, Pliquett UF, Langer R, et al. Transdermal transport of DNA antisenseoligonucleotides by electroporation. Biochem Biophys Res Com, 1995,212: 286.
  • 10李端,刘德林,朱明,杨香媛,施辛,李征.用高效液相色谱法测定萘普生片和萘普生钠片的生物利用度[J].上海医科大学学报,1990,17(3):216-220. 被引量:13

共引文献10

同被引文献17

  • 1徐文,孙进,张婷婷,马博,陈大为,何仲贵.HPLC法测定冬凌草甲素的平衡溶解度和表观油水分配系数[J].沈阳药科大学学报,2007,24(4):220-222. 被引量:35
  • 2BRAQUET P, SPINNEWYN B,BRAQUET M, et al. 52021 and related compounds : a new series of highly specific PAF - acether receptor an- tagonists isolated from Ginkgo biloba[ J]. Blood Vessels, 1985,16,558.
  • 3BRAQUER P. The ginkgolides : potent platelet - activating factor antag- onists isolated from Ginkgo biloba L: chemistry, pharmacology and clin- ical applications [ J ]. Drugs Future, 1987,12 (7) :643.
  • 4STR? MGAARD K,NAKANISHI K. Chemistry and Biology of Terpene Trilactones from. Ginkgo Biloba[ J]. Angew. Chem. Int. Ed. , 2004,43: 1640.
  • 5TANAKA K, KESTER KD, BEROVA N, et al. Preparation of ginkgolide and F - seco - ginkgolide lactols : the unique reactivity of c~ - hydroxy lactones toward NaBH4 [ J ]. Tetrahedron Letters,2005,46 ( 3 ) : 531.
  • 6ZHU WL, CHEN G, HU LH,et al. QSAR analyses on ginkgolides and their analogues using CoMFA, CoMSIA, and HQSAR [ J ]. Bioorganic & Medical Chemistry ,2005,13:313.
  • 7VAN BEEK TA. Ginkgolides and bilobalide : Their physical,chromato- graphic and spectroscopic properities [ J ]. Bioorganic & Medicinal Chemistry ,2005,13:5001.
  • 8卡米尔·乔冶·维尔穆特创新药物化学,第2版[M].广州:广东世界图书出版公司,2005:447.
  • 9中国药品生物制品检定所.中国药品检验标准操作规范[M]北京:中国医药科技出版社,2005.313-324.
  • 10Rhee YS, Choi JG, Chi SC,et al. Transderrnal delivery of ketoprofen using microemulsions[J]. Int J Pharm, 2001, 228: 161- 170

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部